Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Echography

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT00657748Phase 2Withdrawn

Lithium and Acetate for Canavan Disease

NCT00162539Not ApplicableCompletedPrimary

Relation Between Maternal Iodine Status and Prenatal Foetal Thyroid Dimension

NCT00016848Completed

Effects of Dietary Carbohydrate and Fat on Hormones

Showing all 3 trials

Research Network

Common Treatments

  • Echography1
  • Lithium Gluconate Drug Glyceryl Triacetate Gta Drug1

Active Sponsors

  • Assistance Publique - Hôpitaux de Paris2
  • European Leukodystrophy Association1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Healthy1
  • Canavan Disease1
  • Aspartoacylase1
  • Leukodystrophy Spongiform1
  • Infantile1

Activity Timeline